short-acting insulin biosimilar (Regenix Biosciences)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameshort-acting insulin biosimilar (Regenix Biosciences)
Drug Alias Nameshort-acting regular human insulin (Regenix Biosciences)regular insulin human (Regenix Biosciences)insulin R
ClassificationBiologics > Biosimilar
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesRegenix Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRegenix Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A